For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

Morrow is now devoting his life to prostate cancer advocacy and urging other younger, high-risk men to get screened early. He ...

PAM50, a genomic biomarker test, can classify prostate cancers into subtypes luminal B and non-luminal B, predicting which ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...

The annual meeting of the American Society for Radiation Oncology was held from Sept. 27 to Oct. 1 in San Francisco, drawing ...

A phase 2 trial tested the efficacy of local stereotactic body radiation therapy (SBRT) use after radical prostatectomy.

Despite SBRT (radiation) to oligometastatic sites, prostate cancer progression still occurs in a majority of patients due to occult microscopic disease.

Ultrasound has long been used for helping doctors see inside the body, but focused high frequency sound waves are offering ...

As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, ...

A look at some of the more unconventional applications of radiation therapy reported at the ASTRO 2025 meeting ...

It is largely due to advances in treatment that there are now more than 220,000 people in Ireland living with or after cancer ...